VERTEX PHARMACEUTICALS INC / MA APIC, Share-based Payment Arrangement, Increase for Cost Recognition
VERTEX PHARMACEUTICALS INC / MA (VRTX) reported APIC, Share-based Payment Arrangement, Increase for Cost Recognition of $173.90 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Shareholders' Equity
us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue · last filed 2026-08-04
- VERTEX PHARMACEUTICALS INC / MA apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-06-30 was $173.90M, a 1.58% increase year-over-year.
- VERTEX PHARMACEUTICALS INC / MA apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-03-31 was $169.90M, a 0.53% increase year-over-year.
- VERTEX PHARMACEUTICALS INC / MA apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-12-31 was $160.80M, a 5.91% decline year-over-year.
- VERTEX PHARMACEUTICALS INC / MA apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-09-30 was $199.30M, a 5.90% increase year-over-year.
- VERTEX PHARMACEUTICALS INC / MA apic, share-based payment arrangement, increase for cost recognition for fiscal 2025 was $700.30M, a 1.24% decline from fiscal 2024.
- VERTEX PHARMACEUTICALS INC / MA apic, share-based payment arrangement, increase for cost recognition for fiscal 2024 was $709.10M, a 21.53% increase from fiscal 2023.
- VERTEX PHARMACEUTICALS INC / MA apic, share-based payment arrangement, increase for cost recognition for fiscal 2023 was $583.50M, a 18.98% increase from fiscal 2022.
- VERTEX PHARMACEUTICALS INC / MA apic, share-based payment arrangement, increase for cost recognition for fiscal 2022 was $490.40M, a 10.08% increase from fiscal 2021.
| Period end | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 month as first filed | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 6 month as first filed | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 9 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 9 month as first filed | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $173.90M 10-Q · filed 2026-08-04 | $343.80M 10-Q · filed 2026-08-04 | $504.60M derived: sum of 3 quarters · filed 2026-08-04 | $703.90M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2026-03-31 | $169.90M 10-Q · filed 2026-05-05 | $330.70M derived: sum of 2 quarters · filed 2026-05-05 | $530.00M derived: sum of 3 quarters · filed 2026-05-05 | $701.20M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-12-31 | $160.80M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $360.10M derived: sum of 2 quarters · filed 2026-02-13 | $531.30M derived: sum of 3 quarters · filed 2026-08-04 | $700.30M 10-K · filed 2026-02-13 | ||||
| 2025-09-30 | $199.30M 10-Q · filed 2025-11-04 | $370.50M derived: sum of 2 quarters · filed 2026-08-04 | $539.50M 10-Q · filed 2025-11-04 | $710.40M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-06-30 | $171.20M 10-Q · filed 2026-08-04 | $340.20M 10-Q · filed 2026-08-04 | $511.10M derived: sum of 3 quarters · filed 2026-08-04 | $699.30M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-03-31 | $169.00M 10-Q · filed 2026-05-05 | $339.90M derived: sum of 2 quarters · filed 2026-05-05 | $528.10M derived: sum of 3 quarters · filed 2026-05-05 | $685.10M derived: sum of 4 quarters · filed 2026-05-05 | ||||
| 2024-12-31 | $170.90M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $359.10M derived: sum of 2 quarters · filed 2026-02-13 | $516.10M derived: sum of 3 quarters · filed 2026-02-13 | $709.10M 10-K · filed 2026-02-13 | ||||
| 2024-09-30 | $188.20M 10-Q · filed 2025-11-04 | $345.20M derived: sum of 2 quarters · filed 2025-11-04 | $538.20M 10-Q · filed 2025-11-04 | $747.30M derived: sum of 4 quarters · filed 2026-02-13 | ||||
| 2024-06-30 | $157.00M 10-Q · filed 2025-08-05 | $350.00M 10-Q · filed 2025-08-05 | $559.10M derived: sum of 3 quarters · filed 2026-02-13 | $690.80M derived: sum of 4 quarters · filed 2026-02-13 | ||||
| 2024-03-31 | $193.00M 10-Q · filed 2025-05-06 | $402.10M derived: sum of 2 quarters · filed 2026-02-13 | $533.80M derived: sum of 3 quarters · filed 2026-02-13 | $653.70M derived: sum of 4 quarters · filed 2026-02-13 | ||||
| 2023-12-31 | $209.10M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $340.80M derived: sum of 2 quarters · filed 2026-02-13 | $460.70M derived: sum of 3 quarters · filed 2026-02-13 | $583.50M 10-K · filed 2026-02-13 | ||||
| 2023-09-30 | $131.70M 10-Q · filed 2024-11-05 | $251.60M derived: sum of 2 quarters · filed 2024-11-05 | $374.40M 10-Q · filed 2024-11-05 | $485.40M derived: sum of 4 quarters · filed 2025-02-13 | ||||
| 2023-06-30 | $119.90M 10-Q · filed 2024-08-02 | $242.70M 10-Q · filed 2024-08-02 | $353.70M derived: sum of 3 quarters · filed 2025-02-13 | $489.00M derived: sum of 4 quarters · filed 2025-02-13 | ||||
| 2023-03-31 | $122.80M 10-Q · filed 2024-05-07 | $233.80M derived: sum of 2 quarters · filed 2025-02-13 | $369.10M derived: sum of 3 quarters · filed 2025-02-13 | $482.70M derived: sum of 4 quarters · filed 2025-02-13 | ||||
| 2022-12-31 | $111.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-13 | $246.30M derived: sum of 2 quarters · filed 2025-02-13 | $359.90M derived: sum of 3 quarters · filed 2025-02-13 | $490.40M 10-K · filed 2025-02-13 | ||||
| 2022-09-30 | $135.30M 10-Q · filed 2023-11-07 | $248.90M derived: sum of 2 quarters · filed 2023-11-07 | $379.40M 10-Q · filed 2023-11-07 | $498.30M derived: sum of 4 quarters · filed 2024-02-15 | ||||
| 2022-06-30 | $113.60M 10-Q · filed 2023-08-02 | $244.10M 10-Q · filed 2023-08-02 | $363.00M derived: sum of 3 quarters · filed 2024-02-15 | $466.70M derived: sum of 4 quarters · filed 2024-02-15 | ||||
| 2022-03-31 | $130.50M 10-Q · filed 2023-05-02 | $249.40M derived: sum of 2 quarters · filed 2024-02-15 | $353.10M derived: sum of 3 quarters · filed 2024-02-15 | $459.00M derived: sum of 4 quarters · filed 2024-02-15 | ||||
| 2021-12-31 | $118.90M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-15 | $222.60M derived: sum of 2 quarters · filed 2024-02-15 | $328.50M derived: sum of 3 quarters · filed 2024-02-15 | $445.50M 10-K · filed 2024-02-15 | ||||
| 2021-09-30 | $103.70M 10-Q · filed 2022-10-28 | $103.65M 10-Q · filed 2021-11-03 | $209.60M derived: sum of 2 quarters · filed 2022-10-28 | $326.60M 10-Q · filed 2022-10-28 | $326.61M 10-Q · filed 2021-11-03 | $424.19M derived: sum of 4 quarters · filed 2023-02-10 | ||
| 2021-06-30 | $105.90M 10-Q · filed 2022-08-05 | $105.92M 10-Q · filed 2021-07-30 | $223.00M 10-Q · filed 2022-08-05 | $222.95M 10-Q · filed 2021-07-30 | $320.49M derived: sum of 3 quarters · filed 2023-02-10 | $420.98M derived: sum of 4 quarters · filed 2023-02-10 | ||
| 2021-03-31 | $117.00M 10-Q · filed 2022-05-06 | $117.04M 10-Q · filed 2021-04-30 | $214.59M derived: sum of 2 quarters · filed 2023-02-10 | $315.08M derived: sum of 3 quarters · filed 2023-02-10 | $433.20M derived: sum of 4 quarters · filed 2023-02-10 | |||
| 2020-12-31 | $97.59M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-10 | $198.08M derived: sum of 2 quarters · filed 2023-02-10 | $316.20M derived: sum of 3 quarters · filed 2023-02-10 | $433.10M 10-K · filed 2023-02-10 | $433.07M 10-K · filed 2021-02-11 | |||
| 2020-09-30 | $100.49M 10-Q · filed 2021-11-03 | $218.61M derived: sum of 2 quarters · filed 2021-11-03 | $335.51M 10-Q · filed 2021-11-03 | $427.58M derived: sum of 4 quarters · filed 2022-02-09 | ||||
| 2020-06-30 | $118.12M 10-Q · filed 2021-07-30 | $235.02M 10-Q · filed 2021-07-30 | $327.09M derived: sum of 3 quarters · filed 2022-02-09 | $413.04M derived: sum of 4 quarters · filed 2022-02-09 | ||||
| 2020-03-31 | $116.90M 10-Q · filed 2021-04-30 | $208.97M derived: sum of 2 quarters · filed 2022-02-09 | $294.92M derived: sum of 3 quarters · filed 2022-02-09 | $384.86M derived: sum of 4 quarters · filed 2022-02-09 | ||||
| 2019-12-31 | $92.07M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-09 | $178.02M derived: sum of 2 quarters · filed 2022-02-09 | $267.96M derived: sum of 3 quarters · filed 2022-02-09 | $362.20M 10-K · filed 2022-02-09 | $362.21M 10-K · filed 2020-02-13 | |||
| 2019-09-30 | $85.96M 10-Q · filed 2020-10-30 | $175.89M derived: sum of 2 quarters · filed 2020-10-30 | $270.13M 10-Q · filed 2020-10-30 | $349.23M derived: sum of 4 quarters · filed 2021-02-11 | ||||
| 2019-06-30 | $89.94M 10-Q · filed 2020-07-31 | $184.18M 10-Q · filed 2020-07-31 | $263.28M derived: sum of 3 quarters · filed 2021-02-11 | $348.72M derived: sum of 4 quarters · filed 2021-02-11 | ||||
| 2019-03-31 | $94.24M 10-Q · filed 2020-05-01 | $173.34M derived: sum of 2 quarters · filed 2021-02-11 | $258.78M derived: sum of 3 quarters · filed 2021-02-11 | $341.30M derived: sum of 4 quarters · filed 2021-02-11 | ||||
| 2018-12-31 | $79.10M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-11 | $164.54M derived: sum of 2 quarters · filed 2021-02-11 | $247.06M derived: sum of 3 quarters · filed 2021-02-11 | $325.66M 10-K · filed 2021-02-11 | ||||
| 2018-09-30 | $85.44M 10-Q · filed 2019-10-31 | $167.96M derived: sum of 2 quarters · filed 2019-10-31 | $246.56M 10-Q · filed 2019-10-31 | $323.21M derived: sum of 4 quarters · filed 2020-02-13 | ||||
| 2018-06-30 | $82.52M 10-Q · filed 2019-08-01 | $161.12M 10-Q · filed 2019-08-01 | $237.77M derived: sum of 3 quarters · filed 2020-02-13 | $312.90M derived: sum of 4 quarters · filed 2020-02-13 | ||||
| 2018-03-31 | $78.60M 10-Q · filed 2019-05-01 | $155.25M derived: sum of 2 quarters · filed 2020-02-13 | $230.39M derived: sum of 3 quarters · filed 2020-02-13 | $304.45M derived: sum of 4 quarters · filed 2020-02-13 | ||||
| 2017-12-31 | $76.65M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-13 | $151.78M derived: sum of 2 quarters · filed 2020-02-13 | $225.85M derived: sum of 3 quarters · filed 2020-02-13 | $295.64M 10-K · filed 2020-02-13 | ||||
| 2017-09-30 | $75.13M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-25 | $149.20M derived: sum of 2 quarters · filed 2018-10-25 | $218.99M 10-Q · filed 2018-10-25 | $278.95M derived: sum of 4 quarters · filed 2019-02-13 | ||||
| 2017-06-30 | $74.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-26 | $143.86M 10-Q · filed 2018-07-26 | $203.82M derived: sum of 3 quarters · filed 2019-02-13 | $265.98M derived: sum of 4 quarters · filed 2019-02-13 | ||||
| 2017-03-31 | $69.79M 10-Q · filed 2018-04-27 | $129.75M derived: sum of 2 quarters · filed 2019-02-13 | $191.91M derived: sum of 3 quarters · filed 2019-02-13 | $254.78M derived: sum of 4 quarters · filed 2019-02-13 | ||||
| 2016-12-31 | $59.96M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-13 | $122.13M derived: sum of 2 quarters · filed 2019-02-13 | $184.99M derived: sum of 3 quarters · filed 2019-02-13 | $241.24M 10-K · filed 2019-02-13 | ||||
| 2016-09-30 | $62.16M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-30 | $125.03M derived: sum of 2 quarters · filed 2017-10-30 | $181.28M 10-Q · filed 2017-10-30 | $226.69M derived: sum of 4 quarters · filed 2018-02-15 | ||||
| 2016-06-30 | $62.87M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-28 | $119.11M 10-Q · filed 2017-07-28 | $164.53M derived: sum of 3 quarters · filed 2018-02-15 | $231.54M derived: sum of 4 quarters · filed 2018-02-15 | ||||
| 2016-03-31 | $56.25M 10-Q · filed 2017-04-28 | $101.66M derived: sum of 2 quarters · filed 2018-02-15 | $168.68M derived: sum of 3 quarters · filed 2018-02-15 | $233.09M derived: sum of 4 quarters · filed 2018-02-15 | ||||
| 2015-12-31 | $45.41M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-15 | $112.43M derived: sum of 2 quarters · filed 2018-02-15 | $176.84M derived: sum of 3 quarters · filed 2018-02-15 | $235.11M 10-K · filed 2018-02-15 | ||||
| 2015-09-30 | $67.02M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-31 | $131.43M derived: sum of 2 quarters · filed 2016-10-31 | $189.70M 10-Q · filed 2016-10-31 | $232.60M derived: sum of 4 quarters · filed 2017-02-23 | ||||
| 2015-06-30 | $64.41M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-01 | $122.68M 10-Q · filed 2016-08-01 | $165.58M derived: sum of 3 quarters · filed 2017-02-23 | $212.17M derived: sum of 4 quarters · filed 2017-02-23 | ||||
| 2015-03-31 | $58.27M 10-Q · filed 2016-05-03 | $101.17M derived: sum of 2 quarters · filed 2017-02-23 | $147.76M derived: sum of 3 quarters · filed 2017-02-23 | $190.45M derived: sum of 4 quarters · filed 2017-02-23 | ||||
| 2014-12-31 | $42.90M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | $89.49M derived: sum of 2 quarters · filed 2017-02-23 | $132.18M derived: sum of 3 quarters · filed 2017-02-23 | $178.97M 10-K · filed 2017-02-23 | ||||
| 2014-09-30 | $46.59M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-30 | $89.28M derived: sum of 2 quarters · filed 2015-10-30 | $136.06M 10-Q · filed 2015-10-30 | $159.60M derived: sum of 4 quarters · filed 2016-02-16 | ||||
| 2014-06-30 | $42.69M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-04 | $89.47M 10-Q · filed 2015-08-04 | $113.01M derived: sum of 3 quarters · filed 2016-02-16 | $144.52M derived: sum of 4 quarters · filed 2016-02-16 | ||||
| 2014-03-31 | $46.79M 10-Q · filed 2015-05-04 | $70.32M derived: sum of 2 quarters · filed 2016-02-16 | $101.83M derived: sum of 3 quarters · filed 2016-02-16 | $143.56M derived: sum of 4 quarters · filed 2016-02-16 | ||||
| 2013-12-31 | $23.53M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-16 | $55.05M derived: sum of 2 quarters · filed 2016-02-16 | $96.78M derived: sum of 3 quarters · filed 2016-02-16 | $128.35M 10-K · filed 2016-02-16 | ||||
| 2013-09-30 | $31.51M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | $73.24M derived: sum of 2 quarters · filed 2014-11-06 | $104.82M 10-Q · filed 2014-11-06 | $132.82M derived: sum of 4 quarters · filed 2015-02-13 | ||||
| 2013-06-30 | $41.73M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-31 | $73.31M 10-Q · filed 2014-07-31 | $101.31M derived: sum of 3 quarters · filed 2015-02-13 | $129.23M derived: sum of 4 quarters · filed 2015-02-13 | ||||
| 2013-03-31 | $31.57M 10-Q · filed 2014-05-05 | $59.58M derived: sum of 2 quarters · filed 2015-02-13 | $87.50M derived: sum of 3 quarters · filed 2015-02-13 | $119.17M derived: sum of 4 quarters · filed 2015-02-13 | ||||
| 2012-12-31 | $28.00M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-13 | $55.92M derived: sum of 2 quarters · filed 2015-02-13 | $87.60M derived: sum of 3 quarters · filed 2015-02-13 | $115.54M 10-K · filed 2015-02-13 | ||||
| 2012-09-30 | $27.92M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07 | $59.60M derived: sum of 2 quarters · filed 2013-11-07 | $87.54M 10-Q · filed 2013-11-07 | $116.80M derived: sum of 4 quarters · filed 2014-02-11 | ||||
| 2012-06-30 | $31.68M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-02 | $59.62M 10-Q · filed 2013-08-02 | $88.88M derived: sum of 3 quarters · filed 2014-02-11 | $118.59M derived: sum of 4 quarters · filed 2014-02-11 | ||||
| 2012-03-31 | $27.94M 10-Q · filed 2013-05-08 | $57.20M derived: sum of 2 quarters · filed 2014-02-11 | $86.91M derived: sum of 3 quarters · filed 2014-02-11 | $147.21M derived: sum of 4 quarters · filed 2014-02-11 | ||||
| 2011-12-31 | $29.27M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-11 | $58.97M derived: sum of 2 quarters · filed 2014-02-11 | $119.27M derived: sum of 3 quarters · filed 2014-02-11 | $119.27M 10-K · filed 2014-02-11 | ||||
| 2011-09-30 | $29.71M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-06 | $90.00M derived: sum of 2 quarters · filed 2012-11-06 | $90.00M 10-Q · filed 2012-11-06 | $141.61M derived: sum of 4 quarters · filed 2013-03-01 | ||||
| 2011-06-30 | $60.29M 10-Q · filed 2012-08-08 | $60.29M 10-Q · filed 2012-08-08 | $111.90M derived: sum of 3 quarters · filed 2013-03-01 | |||||
| 2011-03-31 | $28.03M 10-Q · filed 2012-05-10 | $51.61M derived: sum of 2 quarters · filed 2013-03-01 | ||||||
| 2010-12-31 | $23.57M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-01 | $91.12M 10-K · filed 2013-03-01 | ||||||
| 2010-09-30 | $67.55M 10-Q · filed 2011-11-03 | |||||||
| 2009-12-31 | $86.72M 10-K · filed 2012-02-22 | |||||||
| 2008-12-31 | $57.98M 10-K · filed 2011-02-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |